7-149250163-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012256.4(ZNF212):c.29G>A(p.Arg10Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,525,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012256.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF212 | NM_012256.4 | c.29G>A | p.Arg10Lys | missense_variant | 2/5 | ENST00000335870.7 | NP_036388.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF212 | ENST00000335870.7 | c.29G>A | p.Arg10Lys | missense_variant | 2/5 | 1 | NM_012256.4 | ENSP00000338572.2 | ||
ZNF212 | ENST00000486371.1 | n.*130G>A | non_coding_transcript_exon_variant | 2/2 | 3 | ENSP00000418281.1 | ||||
ZNF212 | ENST00000486371.1 | n.*130G>A | 3_prime_UTR_variant | 2/2 | 3 | ENSP00000418281.1 | ||||
ZNF212 | ENST00000462724.1 | n.*126-1G>A | splice_acceptor_variant, intron_variant | 5 | ENSP00000418167.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152056Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000384 AC: 7AN: 182366Hom.: 0 AF XY: 0.0000416 AC XY: 4AN XY: 96138
GnomAD4 exome AF: 0.00000874 AC: 12AN: 1373252Hom.: 0 Cov.: 30 AF XY: 0.00000741 AC XY: 5AN XY: 674320
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2023 | The c.29G>A (p.R10K) alteration is located in exon 2 (coding exon 2) of the ZNF212 gene. This alteration results from a G to A substitution at nucleotide position 29, causing the arginine (R) at amino acid position 10 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at